Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Size isn't everything.

J R Hampton1

  • 1Cardiology Department, University Hospital, Nottingham NG7 2UH, UK. john.hampton@nottingham.ac.uk

Statistics in Medicine
|September 27, 2002
PubMed
Summary
This summary is machine-generated.

Large clinical trials are not always necessary, especially for breakthrough treatments. Trial relevance and clinical significance often outweigh sheer size for demonstrating treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The end of clinical freedom.

International journal of epidemiology·2011
Same author

Effect of aggregating agents on the electrophoretic mobility of human platelets.

British medical journal·2010
Same author

Microdisplacement printing.

Nano letters·2005
Same author

Thermally enhanced neutralization in hyperthermal energy ion scattering.

Physical review letters·2003
Same author

Pathological features of witnessed out-of-hospital cardiac arrest presenting with ventricular fibrillation.

Resuscitation·2001
Same author

Geographical distribution of cardiac arrest in Nottinghamshire.

Resuscitation·2001
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Area of Science:

  • Clinical research methodology
  • Biostatistics
  • Evidence-based medicine

Background:

  • Modern clinical trials frequently involve large patient cohorts, with statisticians advocating for substantial sample sizes to ensure reliable outcomes.
  • The necessity of large-scale studies is questioned when highly effective treatments emerge for previously untreatable conditions.

Observation:

  • For diseases with no prior effective treatments, a small trial can suffice to demonstrate a treatment's efficacy (e.g., oranges for scurvy).
  • Large trials are primarily required to detect subtle differences between treatments or small treatment effects.
  • Meta-analyses combining small trials can be unreliable and may obscure adverse effects of individual interventions.

Findings:

  • The clinical relevance of a trial's findings is often more critical than its statistical size.

Related Experiment Videos

  • Equivalence trials, while statistically rigorous, may necessitate large sample sizes, prompting debate among clinicians regarding the need for absolute statistical precision.
  • Clinical trial designs do not always mirror real-world clinical practice.

    • Implications:

    • Clinical trial design should prioritize clinical relevance and real-world applicability over solely focusing on large sample sizes.
    • The interpretation of meta-analyses from small trials requires caution due to potential misleading results and hidden adverse events.
    • Future research should explore optimal trial designs that balance statistical rigor with clinical significance and practical feasibility.